From: Antibiotic resistance and molecular epidemiology of Staphylococcus aureusin Nigeria
 | Number (%) of resistant isolates among: | ||
---|---|---|---|
Antibiotic | MSSA (n = 57) | MRSA (n = 11) | Total (n = 68) |
Penicillin | 49 (86) | 11 (100) | 60 (88.2) |
Oxacillin | 0 (0) | 11 (100) | 11 (16.2) |
Teicoplanin | 0 (0) | 0 (0) | 0 (0) |
Vancomycin | 0 (0) | 0 (0) | 0 (0) |
Gentamicin | 1 (1.8) | 9 (81.8) | 10 (14.7) |
Tetracycline | 27 (47.4) | 11 (100) | 38 (55.9) |
Ciprofloxacin | 12 (21.1) | 8 (72.7) | 20 (29.4) |
Moxifloxacin | 0 (0) | 7 (63.6) | 7 (10.3) |
Trimethoprim/sulfamethoxazole | 39 (68.4) | 10 (90.9) | 49 (72.1) |
Phosphomycin | 0 (0) | 0 (0) | 0 (0) |
Fusidic acid | 0 (0) | 0 (0) | 0 (0) |
Erythromycin | 2 (3.5) | 6 (54.5) | 8 (11.8) |
Clindamycin | 0 (0) | 6 (54.5) | 6 (8.8) |
Rifampicin | 0 (0) | 0 (0) | 0 (0) |
Daptomycin | 0 (0) | 0 (0) | 0 (0) |
Mupirocin | 0 (0) | 0 (0) | 0 (0) |
Linezolid | 0 (0) | 0 (0) | 0 (0) |
Tigecycline | 0 (0) | 0 (0) | 0 (0) |